The award supports entrepreneurial scientists and emerging biotechnology start-ups to accelerate early drug discovery and innovation for the potential benefit of patients worldwide.

Seen Therapeutics is uncovering a hidden world of tumor-specific antigens and engineering antibody-driven medicines to precisely target them. Using advanced structural and computational proteomics, Seen reveals cancer-specific features invisible to conventional discovery methods to create more selective and effective therapies.